ATE302000T1 - Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen - Google Patents

Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen

Info

Publication number
ATE302000T1
ATE302000T1 AT01943711T AT01943711T ATE302000T1 AT E302000 T1 ATE302000 T1 AT E302000T1 AT 01943711 T AT01943711 T AT 01943711T AT 01943711 T AT01943711 T AT 01943711T AT E302000 T1 ATE302000 T1 AT E302000T1
Authority
AT
Austria
Prior art keywords
depression
treatment
pharmaceutical composition
composition containing
famotidine
Prior art date
Application number
AT01943711T
Other languages
English (en)
Inventor
Anna Racz
Peter Kovacs
Csilla Varga
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE302000T1 publication Critical patent/ATE302000T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT01943711T 2000-06-06 2001-06-06 Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen ATE302000T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0002154A HUP0002154A3 (en) 2000-06-06 2000-06-06 Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression
PCT/HU2001/000065 WO2001093863A2 (en) 2000-06-06 2001-06-06 Pharmaceutical compositions for the treatment of depression or symptoms suggesting depression

Publications (1)

Publication Number Publication Date
ATE302000T1 true ATE302000T1 (de) 2005-09-15

Family

ID=89978380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943711T ATE302000T1 (de) 2000-06-06 2001-06-06 Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen

Country Status (10)

Country Link
US (1) US20040010021A1 (de)
EP (1) EP1289520B1 (de)
JP (1) JP2003535133A (de)
AT (1) ATE302000T1 (de)
AU (1) AU2001266242A1 (de)
DE (1) DE60112750T2 (de)
DK (1) DK1289520T3 (de)
ES (1) ES2247137T3 (de)
HU (1) HUP0002154A3 (de)
WO (1) WO2001093863A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption
EP2939675B1 (de) 2012-12-28 2019-09-04 Shin Nippon Biomedical Laboratories, Ltd. Oct3-aktivitätshemmer mit einem imidazopyridinderivat als wirkstoff und oct3-nachweismittel
WO2015002150A1 (ja) 2013-07-03 2015-01-08 株式会社新日本科学 新規化合物，有機カチオントランスポーター３の検出剤及び活性阻害剤
WO2015163832A1 (en) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. An ibuprofen and famotidine combined composition having improved stability
IL311338A (en) * 2024-03-07 2025-10-01 Ariel Scient Innovations Ltd Using hyaluronic acid to treat mental disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5352688A (en) * 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
WO1995001784A1 (en) * 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-sucralfate-antiflatulent combinations
AU7218294A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate combinations

Also Published As

Publication number Publication date
US20040010021A1 (en) 2004-01-15
ES2247137T3 (es) 2006-03-01
DE60112750D1 (de) 2005-09-22
EP1289520A2 (de) 2003-03-12
DE60112750T2 (de) 2006-06-08
HU0002154D0 (en) 2000-08-28
AU2001266242A1 (en) 2001-12-17
WO2001093863A2 (en) 2001-12-13
HUP0002154A3 (en) 2002-06-28
WO2001093863A3 (en) 2002-05-02
HUP0002154A2 (hu) 2002-04-29
EP1289520B1 (de) 2005-08-17
DK1289520T3 (da) 2005-10-17
JP2003535133A (ja) 2003-11-25

Similar Documents

Publication Publication Date Title
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DE60320095D1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
ECSP045115A (es) INDOL-2-CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa
DE60331537D1 (de) Kombinationen zur behandlung von multiplem myelom
HRP20090058A2 (hr) Prekursorski oblici lijekova za aminokiseline s pobuđivačkom aktivnosti
DE602006021444D1 (de) Therapie zur behandlung der überaktiven blase
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
ATE369861T1 (de) Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
MX2023003675A (es) Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos.
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
WO2001062799A3 (en) Method for inhibiting angiogenesis using molecules that enhance plasmin activity
DK1343472T3 (da) Thixotropisk næsespray
ATE499933T1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
ATE302000T1 (de) Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
MX2025002176A (es) Inhibidores de tyk2 y usos de los mismos
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1289520

Country of ref document: EP

REN Ceased due to non-payment of the annual fee